In a phase 3 trial, inebilizumab, a monoclonal antibody targeting CD19+ B cells, reduced flare rates and improved treatment-free and glucocorticoid-free remission in patients with immunoglobulin G4-related...
A recent study found that carrimycin significantly improved immune function and reduced disease severity in patients with tumors who have sepsis, highlighting its potential as an effective immune-modulating...
The American Academy of Otolaryngology-Head and Neck Surgery Foundation released a set of guidelines that outline evidence-based recommendations on the use of immunotherapy for inhalant allergy for...
Patients with melanoma and who are being treated with PD-1 inhibitors have an increased risk of experiencing immune-related neurologic adverse events, compared with patients who are not being treated with...
This COVID-19 roundup includes a summary of studies on the effective treatment options for patients with long COVID, the risk of patients developing medical or mental health conditions post-hospitalization...
This COVID-19 roundup includes coverage of the FDA’s simpler vaccination schedule and authorization of new treatment, decline in pediatric asthma diagnoses during pandemic, and a new treatment combination...
The updates and recommendations by the CDC and several organizations include the addition of the COVID-19 vaccine for pediatric patients and a new pneumococcal conjugate vaccine.
This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...
The Advisory Committee on Immunization Practices has released its updates to the annual immunization schedules for 2023 that includes new sections on COVID-19 and polio vaccine recommendations.
This COVID-19 roundup includes coverage on vaccine safety for older adults, the efficacy of fluvoxamine on COVID-19 symptoms, the use of convalescent plasma transfusion in immunocompromised patients, and...
